A key committee of the European Medicines Agency has recommended approval for an injectable version of Merck's cancer drug Keytruda, paving the way for potential authorization across the European Union. This subcutaneous formulation aims to offer a more convenient alternative to intravenous administration for patients with various cancers. The recommendation, issued on September 19, 2025, follows positive clinical data and could enhance treatment accessibility in Europe.

The U.S. Food and Drug Administration has granted approval for an injectable version of Merck's blockbuster cancer drug Keytruda, marking a significant advancement in treatment options for patients with certain types of cancer. This subcutaneous formulation promises greater convenience over the traditional intravenous method, potentially improving patient adherence and reducing healthcare burdens. The decision, announced on September 19, 2025, underscores ongoing innovations in oncology amid rising demands for more accessible therapies.

The U.S. Food and Drug Administration has granted accelerated approval to Forzinity, the first treatment for Barth syndrome, a rare X-linked genetic disorder primarily affecting males. Developed by Stealth Biotherapeutics, the therapy targets mitochondrial dysfunction underlying the condition, offering new hope for patients with this life-threatening disease. This milestone follows years of advocacy and highlights progress in addressing ultra-rare disorders.

KFF Health News briefings for September 15 and 16, 2025, cover key healthcare developments including policy changes, medical breakthroughs, and public health updates. The reports provide objective insights into U.S. health issues. They highlight ongoing debates on insurance and access.

Science news roundups from September 14-16, 2025, cover potential life on Mars, theoretical black hole stars, a global diabetes crisis, and miracle eye drops for vision restoration. The reports present consistent information across the sources without contradictions. These developments span space exploration and medical breakthroughs, informing the public on current scientific progress.

Recent medical marvels include advancements in gene editing and AI-driven diagnostics, promising to revolutionize healthcare delivery. Sources report on new treatments for chronic diseases, with some debates over ethical implications and accessibility. These developments were highlighted in science news summaries and health briefings.

Det 31. europæiske symposium om urogenital radiologi er planlagt for september 2025 i Stockholm. Begivenheden er blevet vurderet som compliant med etiske standarder. Det vil foregå på Stockholm Waterfront Congress Centre.

A new Ebola outbreak has been declared in the Democratic Republic of Congo. Health authorities confirmed cases following recent reports. Efforts are underway to contain the spread through vaccination and monitoring.

The World Health Organization has declared that the mpox outbreak in Africa is no longer a global health emergency. The decision follows a decline in cases and improved control measures. Mpox remains endemic in parts of Africa, with symptoms including fever and lesions.

A new Ebola outbreak has been confirmed in the Kasai region of the Democratic Republic of Congo. Authorities reported 28 suspected infections and 15 deaths. Health officials are mobilizing response teams to contain the spread.

Health authorities in the Democratic Republic of Congo have confirmed a new Ebola outbreak in the Kasai region. The outbreak involves 28 suspected infections and 15 deaths as of the latest reports.

Researchers detected a carcinogenic metal in a study featured in the September 4, 2025, Science Magazine. This finding raises concerns about environmental and health impacts.

On September 5, 2025, Science Friday aired an episode exploring toxic air pollution from common household items like candles and hairstyling products. The show also covered sand dune science and an interview with former CDC scientist Demetre Daskalakis.

Regulatory developments were noted for blood-based biomarker tests to detect Alzheimer's disease. These tests represent an emerging tool for early diagnosis. The update was part of a health innovation brief.

Illumina introduced an AI tool aiding in the diagnosis of rare diseases. This innovation enhances genetic analysis for complex conditions. It was highlighted in biotech news updates.

Summit's new drug for lung cancer demonstrated promising results in recent assessments. This development is part of ongoing biotech advancements in oncology. It was reported alongside other health innovations.

Studies on cellular senescence removal in mice achieved a 35% improvement in outcomes, highlighting potential for human applications. This breakthrough focuses on clearing 'zombie cells' to enhance healthspan. It was shared as part of emerging longevity strategies.

Human trials on dysregulated nutrient sensing via the mTOR pathway showed significant results, including a 50% reduction in infections after an 8-week treatment. The study by Joan Mannick demonstrated lasting effects for a year. This advances longevity and health research.

Histotripsy, a non-invasive technique using ultrasound for tissue destruction, was noted as a key innovation in recent medical updates. It offers potential for treating tumors without surgery. This development was part of a roundup of breakthroughs.

A new study questions the standard use of aspirin by comparing it to clopidogrel in certain medical contexts. The research suggests potential shifts in treatment protocols based on outcomes. This was highlighted as part of recent medical advancements.